论文部分内容阅读
血液制品是由健康人血浆或经特异免疫的人血浆,经分离、提纯或由重组DNA技术制成的血浆蛋白组分以及血液细胞有形成分。如其中的人血白蛋白、人凝血因子、人免疫球蛋白等,用于被动免疫预防和治疗。血液制品的生产过程产生工业废水,需要对其进行处理。目前,废水生物处理工艺有SBR工艺、AB工艺、CASS工艺和LINPOR工艺等。提高废水处理效果,减小运行管理和设备投资费用,减少污水处理厂占地面积和提高工艺适应能力仍然是废水处理的关键。主要介绍血液制品生产废水的DAT-IAT处理工艺。废水处理符合当代人日趋增强的环保意识的要求,应重视推广和研究。
A blood product is a plasma protein component, as well as a hematopoietic cell component, isolated, purified, or made by recombinant DNA technology, from healthy human plasma or specifically immunized human plasma. Such as human albumin, human coagulation factors, human immunoglobulin, for passive immunization prevention and treatment. The production of blood products produces industrial waste that needs to be disposed of. At present, the wastewater biological treatment process SBR technology, AB technology, CASS technology and LINPOR process. Increasing wastewater treatment efficiency, reducing operational management and equipment investment costs, reducing the footprint of sewage treatment plants and improving process adaptability are still the keys to wastewater treatment. Mainly introduces the DAT-IAT treatment process of blood product production wastewater. Wastewater treatment meets the increasingly stringent environmental awareness requirements of the present generation, and emphasis should be placed on promotion and research.